Venus Remedies Holds Talks With Three MNCs Over Its New Anti-infective Sulbactomax
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's Venus Remedies has opened dialogue with three multinational companies to hammer out a marketing and supply deal for a combination anti-infective drug Sulbactomax that it says is "capable of replacing a larger share of the most preferred ceftriaxone world market.